BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Neurocampus - ECPv4.9.10//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Neurocampus
X-ORIGINAL-URL:https://www.bordeaux-neurocampus.fr/en/
X-WR-CALDESC:Events for Bordeaux Neurocampus
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20180921T140000
DTEND;TZID=Europe/Paris:20180921T150000
DTSTAMP:20260415T092430
CREATED:20181130T101023Z
LAST-MODIFIED:20181130T101023Z
UID:101763-1537538400-1537542000@www.bordeaux-neurocampus.fr
SUMMARY:Seminar - Léon Tremblay
DESCRIPTION:21 sept. 2018 à 14:00 (Amphi Broca) \nLéon TremblayDirecteur de Recherche\, Institute of Cognitive Science Marc Jeannerod\, Lyon\, France. \nInvitant :Dominique Guehl\, INCIA \nAbstract :\nThanks to the non-human primate (NHP)\, we have shown that the pharmacological disturbance of the anterior striatum or of external globus pallidus triggers a set of motivation and movement disorders\, depending on the functional sub-territory involved. One can\, therefore\, assume that the aberrant activity of the different sub-territories of basal ganglia (BG) could lead to different behavioral disorders in neuropsychiatric disorders as Tourette’s syndrome and Parkinson’s disease. We are now addressing in the NHP the impact of modulating dopamine or serotonin within the BG on behavioral disorders. Indeed\, we have shown a prominent role of serotonergic degeneration within the ventral striatum and caudate nucleus in neuropsychiatric symptoms in de novo PD patients. Of note\, the serotonergic modulation of these BG regions in the NHP plays also a critical role in the induction or treatment of behavioral disorders. Given that both dopamine and serotonin are targeted to treat neuropsychiatric disorders\, we are studying the effects of modulating dopamine and serotonin transporters in the different territories of the striatum\, and more particularly within the ventral striatum on decision-making processing at both behavioral and neuronal levels. Finally\, we evidence the need to extend the pharmacological approach to the receptors of these two neuromodulator systems as the use of substances targeting receptor subtypes preferentially localized in the associative and limbic territories of BG could be very effective to specifically improve the behavioral disorders in Parkinson’s disease\, Gilles de la Tourette syndrome but also in several psychiatric disorders such as depression\, anxiety\, anorexia\, or impulse control disorders. \n
URL:https://www.bordeaux-neurocampus.fr/en/event/seminar-leon-tremblay/
CATEGORIES:Seminars
END:VEVENT
END:VCALENDAR